Cite
Protection against H5N1 Influenza Virus Induced by Matrix-M Adjuvanted Seasonal Virosomal Vaccine in Mice Requires Both Antibodies and T Cells.
MLA
Cox, Freek, et al. “Protection against H5N1 Influenza Virus Induced by Matrix-M Adjuvanted Seasonal Virosomal Vaccine in Mice Requires Both Antibodies and T Cells.” PLoS ONE, vol. 10, no. 12, Dec. 2015, pp. 1–17. EBSCOhost, https://doi.org/10.1371/journal.pone.0145243.
APA
Cox, F., Baart, M., Huizingh, J., Tolboom, J., Dekking, L., Goudsmit, J., Saeland, E., & Radošević, K. (2015). Protection against H5N1 Influenza Virus Induced by Matrix-M Adjuvanted Seasonal Virosomal Vaccine in Mice Requires Both Antibodies and T Cells. PLoS ONE, 10(12), 1–17. https://doi.org/10.1371/journal.pone.0145243
Chicago
Cox, Freek, Matthijs Baart, Jeroen Huizingh, Jeroen Tolboom, Liesbeth Dekking, Jaap Goudsmit, Eirikur Saeland, and Katarina Radošević. 2015. “Protection against H5N1 Influenza Virus Induced by Matrix-M Adjuvanted Seasonal Virosomal Vaccine in Mice Requires Both Antibodies and T Cells.” PLoS ONE 10 (12): 1–17. doi:10.1371/journal.pone.0145243.